Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Inovio Biomedical Corp (INO)  
$0.58 0.00 (0.00%) as of 4:30 Wed 1/24


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 169,410,000
Market Cap: 97.83(M)
Last Volume: 3,856,623 Avg Vol: 3,845,860
52 Week Range: $0.35 - $0.885
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Inovio Pharmaceuticals is a biotechnology company focused on bringing the designed deoxyribonucleic acid (DNA) medicines and vaccines to help protect people from infectious diseases, including COVID-19, and to help treat people with cancer, and conditions associated with human papillomavirus. Co.'s DNA medicines pipeline is comprised of three types of product candidates: prophylactic DNA vaccines, therapeutic DNA immunotherapies, and DNA encoded monoclonal and bispecific antibodies, all of which utilize the two components of Co.'s integrated platform, SynCon® and CELLECTRA®. Co. is evaluating the feasibility of, conducting or planning clinical studies of its DNA medicines.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 5,700 49,676
Total Sell Value $0 $0 $3,192 $85,601
Total People Sold 0 0 1 3
Total Sell Transactions 0 0 1 7
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 488
  Page 6 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Weiner David B. Director   –       •      –    2021-03-08 4 OE $0.00 $0 D/D 11,667 847,052     -
   Weiner David B. Director   –       •      –    2021-03-08 4 AS $9.18 $32,135 D/D (3,500) 835,385 -7%     
   Humeau Laurent Chief Scientific Officer   •       –      –    2021-03-08 4 D $8.91 $61,319 D/D (6,882) 55,452     -
   Humeau Laurent Chief Scientific Officer   •       –      –    2021-03-08 4 OE $0.00 $0 D/D 19,900 62,334     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2021-03-08 4 D $8.91 $303,537 D/D (34,067) 1,163,816     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2021-03-08 4 OE $0.00 $0 D/D 63,700 1,197,883     -
   Kies Peter CFO   •       –      –    2021-03-05 4 D $9.19 $133,935 D/D (14,574) 132,282     -
   Kies Peter CFO   •       –      –    2021-03-05 4 OE $0.00 $0 D/D 27,566 146,856     -
   Weiner David B. Director   –       •      –    2021-03-05 4 OE $0.00 $0 D/D 11,666 838,885     -
   Humeau Laurent Chief Scientific Officer   •       –      –    2021-03-05 4 D $9.19 $88,518 D/D (9,632) 42,434     -
   Humeau Laurent Chief Scientific Officer   •       –      –    2021-03-05 4 OE $0.00 $0 D/D 27,566 52,066     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2021-03-05 4 D $9.19 $590,274 D/D (64,230) 1,134,183     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2021-03-05 4 OE $0.00 $0 D/D 120,100 1,198,413     -
   Benito Simon X Director   –       •      –    2021-02-16 4 AS $14.68 $29,360 D/D (2,000) 51,650 -33%     
   Benito Simon X Director   –       •      –    2021-02-16 4 OE $3.56 $7,120 D/D 2,000 53,650     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2021-02-03 4 AS $14.24 $890,000 D/D (62,500) 1,078,313 -41%     
   Kim Jong Joseph Chief Executive Officer   •       •      –    2021-02-03 4 OE $4.56 $285,000 D/D 62,500 1,140,813     -
   Kim Jong Joseph Chief Executive Officer   •       •      –    2021-02-01 4 AS $15.00 $1,500,000 D/D (100,000) 1,078,313 -46%     
   Shea Jacqueline Elizabeth Chief Operating Officer   •       –      –    2021-02-01 4 AS $15.00 $426,383 D/D (28,336) 38,535 -46%     
   Shea Jacqueline Elizabeth Chief Operating Officer   •       –      –    2021-02-01 4 OE $3.62 $81,001 D/D 22,376 66,871     -
   Shea Jacqueline Elizabeth Chief Operating Officer   •       –      –    2021-01-28 4 AS $12.04 $201,225 D/D (16,713) 44,495 -8%     
   Shea Jacqueline Elizabeth Chief Operating Officer   •       –      –    2021-01-28 4 OE $3.62 $199,998 D/D 55,248 61,208     -
   Shea Jacqueline Elizabeth Chief Operating Officer   •       –      –    2021-01-27 4 AS $12.01 $340,494 D/D (28,336) 5,960 -31%     
   Shea Jacqueline Elizabeth Chief Operating Officer   •       –      –    2021-01-27 4 OE $3.62 $81,001 D/D 22,376 34,296     -
   Shepard Jay Director   –       •      –    2021-01-15 4 OE $0.00 $0 D/D 4,274 4,274     -
  488 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 6 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us